Berlin, Germany

Kerstin Stief

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Magforce Ag. Active years: 2014-2017.


% Patents Active = 50.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kerstin Stief: Innovator in Magnetic Nanoparticle Technology

Introduction

Kerstin Stief is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of biocompatible magnetic nanoparticles. With a total of 2 patents, her work focuses on innovative solutions for therapeutic applications, particularly in cancer treatment.

Latest Patents

Kerstin's latest patents revolve around the development of magnetic transducers. These embodiments relate to the production of biocompatible magnetic nanoparticles with a high specific absorption rate (SAR) value. When exposed to an alternating magnetic field, these nanoparticles generate a substantial amount of heat. This heat can be utilized for various therapeutic purposes, especially in combating cancer.

Career Highlights

Kerstin Stief is associated with Magforce AG, a company dedicated to advancing cancer treatment technologies. Her expertise in magnetic nanoparticles has positioned her as a key figure in the field. Her innovative approaches have the potential to revolutionize therapeutic methods for cancer patients.

Collaborations

Kerstin collaborates with notable professionals in her field, including Norbert Waldoefner and Norbert Waldöfner. These partnerships enhance her research and development efforts, contributing to the advancement of magnetic nanoparticle technology.

Conclusion

Kerstin Stief's work in the field of magnetic nanoparticles showcases her dedication to improving cancer treatment methodologies. Her innovative patents and collaborations highlight her significant impact on the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…